{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:17:08Z","timestamp":1791497828992,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Autologous platelet-rich plasma products can significantly vary with respect to platelet concentration, the presence of additional cellularity, and the use of additives. Therefore, the utility of each formulation for treating chronic wounds needs to be established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To establish the efficacy of up to 12 weeks of treatment with Aurix hematogel for healing diabetic foot ulcers against usual and customary care including any wound modality in 129 patients using a Medicare Coverage with Evidence Development paradigm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>This pragmatic randomized controlled trial was conducted in 28 real-world outpatient wound care sites using an inclusive design that included participants with various health risks, comorbidities (eg, peripheral arterial disease, smoking), and any wound severity (Wagner 1\u20134).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Kaplan-Meier analysis showed a significant (log-rank <jats:italic toggle=\"yes\">P<\/jats:italic> = .0476) time-to-heal advantage, with 48.5% of wounds healing with Aurix hematogel compared with 30.2% with usual and customary care. A higher percentage of healing was observed for Aurix across all wound severities (Wagner grade 1\u20134). Subgroup analysis revealed a significant healing advantage for Aurix when treating wounds accompanied by peripheral arterial disease and a demonstrated advantage for smokers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>This first Coverage with Evidence Development study in wound care demonstrates the effectiveness of Aurix for treating diabetic foot ulcers in Medicare beneficiaries.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000577140.19174.9e","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:43Z","timestamp":1566432043000},"page":"416-426","source":"Crossref","is-referenced-by-count":30,"title":["Aurix Gel Is an Effective Intervention for Chronic Diabetic Foot Ulcers: A Pragmatic Randomized Controlled Trial"],"prefix":"10.1097","volume":"32","author":[{"given":"Warren","family":"Gude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferial","family":"Abood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"bib1-20230923","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14737167.2019.1567337","article-title":"Current health and economic burden of chronic diabetic osteomyelitis","volume":"19","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/iwj.12940","article-title":"Barriers and enablers to patient recruitment for randomized controlled trials on treatment for chronic wounds: a systematic review","volume":"15","year":"2018","journal-title":"Int Wound J"},{"issue":"6","key":"bib3-20230923","first-page":"68","article-title":"A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","year":"2006","journal-title":"Ostomy Wound Manage"},{"issue":"4","key":"bib4-20230923","first-page":"12","article-title":"A prospective, randomized, blinded, controlled trial comparing transdermal continuous oxygen delivery to moist wound therapy for the treatment of diabetic foot ulcers","volume":"63","year":"2017","journal-title":"Ostomy Wound Manage"},{"issue":"1","key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1534734609331597","article-title":"Apligraf in the treatment of neuropathic diabetic foot ulcers","volume":"8","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"issue":"11","key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-8587(18)30240-7","article-title":"LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"e45","key":"bib7-20230923","first-page":"1","article-title":"A primer on effectiveness and efficacy trials","volume":"5","year":"2014","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2337\/diacare.15.11.1598","article-title":"Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo","volume":"15","year":"1992","journal-title":"Diabetes Care"},{"issue":"3","key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2337\/diacare.24.3.483","article-title":"Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","year":"2015","journal-title":"Blood Rev"},{"issue":"5","key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOH.0b013e32832e9dc6","article-title":"The platelet proteome","volume":"16","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"bib15-20230923","first-page":"e38","article-title":"Use of platelet rich plasma on wound healing: a systematic review and meta-analysis [published online ahead of print September 15, 2011]","volume":"11","year":"2011","journal-title":"Eplasty"},{"issue":"1","key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000477353","article-title":"A review of platelet-rich plasma: history, biology, mechanism of action, and classification","volume":"4","year":"2018","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"bib17-20230923","first-page":"29","article-title":"US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine","volume":"28","year":"2015","journal-title":"J Knee Surg"},{"issue":"7","key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","year":"2012","journal-title":"Arthroscopy"},{"issue":"1","key":"bib19-20230923","first-page":"12","article-title":"Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells","volume":"6","year":"2008","journal-title":"Blood Transfus"},{"issue":"4","key":"bib20-20230923","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijom.2004.10.018","article-title":"Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in-vitro study","volume":"34","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"bib21-20230923","first-page":"105","article-title":"Platelet gel stimulates proliferation of human dermal fibroblasts in vitro","volume":"16","year":"2007","journal-title":"Acta Dermatoven APA"},{"key":"bib22-20230923","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000098948","article-title":"Homologous activated platelets stimulate differentiation and proliferation of primary human bone cells","volume":"184","year":"2006","journal-title":"Cells Tissues Organs"},{"key":"bib23-20230923","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-017-0324-1","article-title":"Treatment of chronic non-heling ulcers using autologous platelet rich plasma: a case series","volume":"24","year":"2017","journal-title":"J Biomed Sci"},{"issue":"1","key":"bib24-20230923","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12968\/jowc.2019.28.1.15","article-title":"Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds","volume":"28","year":"2019","journal-title":"J Wound Care"},{"issue":"2","key":"bib25-20230923","first-page":"e2145","article-title":"Efficacy of homologous, platelet-rich plasma dressing in chronic non-healing ulcers: an observational study","volume":"10","year":"2018","journal-title":"Cureus"},{"issue":"12","key":"bib26-20230923","doi-asserted-by":"crossref","first-page":"784","DOI":"10.12968\/jowc.2017.26.12.784","article-title":"Management of chronic diabetic foot ulcers using platelet-rich plasma","volume":"26","year":"2017","journal-title":"J Wound Care"},{"issue":"9","key":"bib27-20230923","doi-asserted-by":"crossref","first-page":"550","DOI":"10.12968\/jowc.2018.27.9.550","article-title":"Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study","volume":"27","year":"2018","journal-title":"J Wound Care"},{"issue":"2","key":"bib28-20230923","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.transci.2016.10.020","article-title":"Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: a single-arm clinical trial","volume":"56","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"bib29-20230923","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4239\/wjd.v9.i10.172","article-title":"Topical application of platelet-rich plasma for diabetic foot ulcers: a systematic review","volume":"9","year":"2018","journal-title":"World J Diabetes"},{"key":"bib31-20230923","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1742-481X.2011.00868.x","article-title":"Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory","volume":"8","year":"2011","journal-title":"Int Wound J"},{"key":"bib32-20230923","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.ASW.0000403249.85131.6f","article-title":"The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel","volume":"24","year":"2011","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"bib33-20230923","first-page":"36","article-title":"A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program","volume":"58","year":"2012","journal-title":"Ostomy Wound Manage"},{"key":"bib34-20230923","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1742-481X.2011.00770.x","article-title":"Effect of platelet rich plasma gel in a physiologically relevant platelet concentration on wounds in persons with spinal cord injury","volume":"8","year":"2011","journal-title":"Int Wound J"},{"issue":"5","key":"bib35-20230923","first-page":"134","article-title":"Synergism in using negative pressure wound therapy with alternated applications of autologous platelet-derived growth factors in treating post-acute surgical wounds","volume":"21","year":"2009","journal-title":"Wounds"},{"key":"bib36-20230923","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/wrr.12193","article-title":"The \u201cWound-QoL\u201d: a short questionnaire measuring quality of life in patients with chronic wounds based on three established disease-specific instruments","volume":"22","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"2 Suppl 1","key":"bib37-20230923","first-page":"3S","article-title":"Growth factor content in PRP and their applicability in medicine","volume":"26","year":"2012","journal-title":"J Biol Regul Agents"},{"issue":"4","key":"bib38-20230923","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3914","article-title":"Platelet-rich plasma therapy\u2014future or trend?","volume":"14","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"bib39-20230923","first-page":"1","article-title":"Platelet-rich plasma: support for its use in wound healing","volume":"83","year":"2010","journal-title":"Yale J Biol Med"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000577140.19174.9e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:25:54Z","timestamp":1695464754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000577140.19174.9e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000577140.19174.9e","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}